<DOC>
	<DOCNO>NCT01905852</DOCNO>
	<brief_summary>Background : - Aortic valve stenosis disease make major heart valve get small . This reduce heart function cause death . Severe aortic stenosis ( AS ) treat couple way , include replace heart valve . Objectives : Researchers want study fibrosis heart . A sub-study test whether heart function blood supply improve valve replacement . Eligibility : - Adults least 18 year old aortic stenosis . Design : - Participants visit clinic 1 day magnetic resonance imaging ( MRI ) heart . This use magnet , radio wave , computer produce detailed picture heart . - After visit , participant aortic valve procedure Washington Hospital Center . A hospital team contact participant 1 year phone email . This follow-up consist 15 minute question participant health status . - Some participant join sub-study . - They give additional medication evaluate blood supply heart . - They visit clinic 1 day MRI heart , part main study , prior aortic valve replacement . - After valve replace hospital , return clinic another MRI . - They follow-up main study .</brief_summary>
	<brief_title>Use Cardiac-MRI Predict Results People With Severe Aortic Stenosis</brief_title>
	<detailed_description>Aortic valve stenosis disease cause narrow major heart valve , reduces heart function cause death . The purpose protocol use magnetic resonance image heart identify patient would benefit replacement diseased valve .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>INCLUSION CRITERIA : Subjects must meet follow inclusion criterion prior enrollment trial : 1 . Severe aortic stenosis define aortic valve area le 1 cm ( 2 ) index area 0.6 cm ( 2 ) /m ( 2 ) echocardiography . 2 . Symptomatic patient aortic stenosis refer medically indicate AVR 3 . LV EF less equal 0.50 4 . Signed informed consent participate study . Specific criterion MR perfusion substudy : 5 . Absence significant coronary lesion presence coronary disease conservative ( medical ) therapy &lt; TAB &gt; . EXCLUSION CRITERIA : 1 . Inability sign write informed consent . 2 . Subjects contraindication MRI scanning , include follow device condition : Cardiac pacemaker implantable defibrillator Cerebral aneurysm clip Neural stimulator ( e.g . TENSUnit ) Any type ear implant Ocular foreign body ( e.g . metal shaving ) Any implanted device ( e.g . insulin pump , drug infusion device ) Metal shrapnel bullet . Atrial fibrillation 3 . Subjects know hypersensitivity , allergy contraindication iodine gadolinium 4 . Impaired renal excretory function , calculate Glomerular Filtration Rate ( GFR ) &lt; 30mL/min/1.73m ( 2 ) . 5 . Contraindications intravenous adenosine infusion : Known hypersensitivity adenosine Known suspect significant bronchoconstrictive bronchospastic disease 2nd 3rd degree atrioventricular ( AV ) block unless permanent pacemaker Sinus bradycardia ( heart rate &lt; 45 bpm ) unless permanent pacemaker Systemic arterial hypotension ( &lt; 90 mmHg ) 6 . Presence coexist severe valvular disorder . 7 . Pregnancy breast feeding ( woman childbearing potential serum urine pregnancy test ) . 8 . Need emergency surgery reason . 9 . Any case practice physician asserts enrollment protocol adversely affect patient treatment course . Specific exclusion criterion MR perfusion substudy : No detectable reversible ischemia pretreatment/procedure cardiac MRI . Subject underwent transcatheter AVR part one transcatheter heart valve trial ( i.e . PARTNER trial pivotal CoreValve trial ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 8, 2014</verification_date>
	<keyword>Transcatheter Aortic Valve Replacement</keyword>
	<keyword>Ejection Fraction</keyword>
	<keyword>Fractional Flow Reserve</keyword>
	<keyword>Myocardial Fibrosis</keyword>
</DOC>